Effect of curcumin on visfatin and zinc-α2-glycoprotein in a rat model of non-alcoholic fatty liver disease

Acta Cir Bras. 2016 Nov;31(11):706-713. doi: 10.1590/S0102-865020160110000001.

Abstract

Purpose:: To investigate the effect of curcumin on visfatin and zinc-α2-glycoprotein (ZAG) expression levels in rats with non-alcoholic fatty liver disease (NAFLD).

Methods:: Fifty-six male rats were randomly divided into a control group (n=16) and model group (n=40) and were fed on a normal diet or a high-fat diet, respectively. Equal volumes of sodium carboxymethyl cellulose (CMC) were intragastrically administered to the control group for 4 weeks. At the end of the 12th week, visfatin and ZAG protein expression levels were examined by immunohistochemistry. Visfatin mRNA levels were measured by semi-quantitative reverse transcription polymerase chain reaction.

Results:: Compared with the control group, the model group showed significantly increased expression of visfatin in liver tissue (P < 0.01) and significantly decreased expression of ZAG (P < 0.01). These effects were ameliorated by curcumin treatment.

Conclusions:: Visfatin and zinc-α2-glycoprotein may be involved in the pathogenesis of NAFLD. Treatment of NAFLD in rats by curcumin may be mediated by the decrease of visfatin and the increase of non-alcoholic fatty liver disease.

MeSH terms

  • Alanine Transaminase / blood
  • Animals
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Anti-Inflammatory Agents, Non-Steroidal / therapeutic use*
  • Antioxidants / administration & dosage
  • Antioxidants / therapeutic use
  • Cholesterol / blood
  • Curcumin / administration & dosage
  • Curcumin / therapeutic use*
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Fatty Acids / metabolism*
  • Liver / pathology
  • Male
  • Nicotinamide Phosphoribosyltransferase / metabolism*
  • Non-alcoholic Fatty Liver Disease / drug therapy
  • Non-alcoholic Fatty Liver Disease / metabolism*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Seminal Plasma Proteins / metabolism*
  • Triglycerides / blood
  • Zn-Alpha-2-Glycoprotein

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antioxidants
  • Fatty Acids
  • Seminal Plasma Proteins
  • Triglycerides
  • Zn-Alpha-2-Glycoprotein
  • Cholesterol
  • Nicotinamide Phosphoribosyltransferase
  • Alanine Transaminase
  • Curcumin